Overexpression of HELLS was reported in several types of cancers, e.g., nasopharyngeal carcinoma, hepatocellular carcinoma, colorectal cancer and pancreatic cancer [49,51,52,53]. This evidence concerns the gene HELLS and colorectal cancer.